Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	National Institute for Health Research 2016

Gelijkaardige items

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
door: Thomas RE Barnes, et al.
Gepubliceerd in: (2016-04-01)

Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
door: Barnes, T, et al.
Gepubliceerd in: (2017)

Disclosing the potential impact of placebo controls in antidepressant trials
door: Stephanie C. Chen, et al.
Gepubliceerd in: (2015-06-01)

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
door: Thomas RE Barnes, et al.
Gepubliceerd in: (2017-09-01)

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
door: Crawford, A, et al.
Gepubliceerd in: (2014)

Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
door: Crawford, A, et al.
Gepubliceerd in: (2014)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
door: Leucht, S, et al.
Gepubliceerd in: (2018)

HOW IMPORTANT IS PLACEBO IN ANTIDEPRESSANT TRIALS?
door: Cipriani, A
Gepubliceerd in: (2010)

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
door: MJ Crawford, et al.
Gepubliceerd in: (2012-02-01)

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
door: Ludovic Trinquart, et al.
Gepubliceerd in: (2012-01-01)

Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
door: Lisa Holper, et al.
Gepubliceerd in: (2020-09-01)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
door: A Schrag, et al.
Gepubliceerd in: (2022-12-01)

Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
door: Wiles, N, et al.
Gepubliceerd in: (2012)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.
door: Norio Sugawara, et al.
Gepubliceerd in: (2015-01-01)

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.
door: Gijsman, H, et al.
Gepubliceerd in: (2004)

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
door: Lewis, G, et al.
Gepubliceerd in: (2011)

Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials
door: Maslej, MM, et al.
Gepubliceerd in: (2021)

Randomized controlled trials for schizophrenia: study designs targeted to distinct goals.
door: Stroup, T, et al.
Gepubliceerd in: (2008)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
door: Ogawa, Y, et al.
Gepubliceerd in: (2017)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
door: Shiraishi Tetsuya, et al.
Gepubliceerd in: (2010-06-01)

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
door: S Banerjee, et al.
Gepubliceerd in: (2013-02-01)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
door: Jakub Tomasik, et al.
Gepubliceerd in: (2015-06-01)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
door: Jakub Tomasik, et al.
Gepubliceerd in: (2015-01-01)

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
door: Wiles, N, et al.
Gepubliceerd in: (2014)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
door: Leucht, S, et al.
Gepubliceerd in: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
door: Leucht, S, et al.
Gepubliceerd in: (2017)

Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials
door: Zhao M, et al.
Gepubliceerd in: (2022-08-01)

Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial
door: Paul Bassett, et al.
Gepubliceerd in: (2020-09-01)

The MATISSE study: a randomised trial of group art therapy for people with schizophrenia
door: Crawford Mike J, et al.
Gepubliceerd in: (2010-08-01)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
door: Leucht, S, et al.
Gepubliceerd in: (2019)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
door: Somaieh Ashrafi, et al.
Gepubliceerd in: (2022-01-01)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
door: Furukawa, T, et al.
Gepubliceerd in: (2016)

Reactions to treatment debriefing among the participants of a placebo controlled trial
door: Crawford Fay, et al.
Gepubliceerd in: (2005-04-01)

Placebo-controlled trial of cytisine for smoking cessation.
door: West, R, et al.
Gepubliceerd in: (2011)

The debate over placebo-controlled trials.
door: Frankllin Miller
Gepubliceerd in: (2005-06-01)

The debate over placebo-controlled trials.
Gepubliceerd in: (2005-06-01)

The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial
door: Mike J. Crawford, et al.
Gepubliceerd in: (2022-04-01)

Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials
door: K. Hagi, et al.
Gepubliceerd in: (2021-04-01)

5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
door: Neyousha Mohammadi, et al.
Gepubliceerd in: (2010-01-01)

5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
door: Neyousha Mohammadi, et al.
Gepubliceerd in: (2010-01-01)